SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
— Financing led by LAV and ARCH Venture Partners with participation from new and existing investors — Appoints Hogan Wan as Chief Financial Officer to lead financial management, strategy and operation SciNeuro Pharmaceuticals (“SciNeuro”), a biotech company pioneering the development of novel treatments for neurodegenerative diseases, today announced the completion of a total of $53 […]